The Government of India is poised to commence a comprehensive Human Papillomavirus (HPV) vaccination initiative on February 28, 2026, with the objective of safeguarding young females against cervical cancer—one of the most prevalent yet predominantly preventable malignancies among the female population. The official launch of this initiative will be conducted by Prime Minister Narendra Modi in Ajmer, Rajasthan, marking the beginning of this crucial public health project.
Key Details
Launch Date: February 28, 2026
Launch Location: Ajmer, Rajasthan
Target Group: Females aged 14 years throughout India
Vaccine Utilized: Gardasil 4 — a quadrivalent HPV vaccine that provides protection against HPV strains commonly associated with cervical cancer and genital warts.
The vaccinations will be provided at no charge through state-operated healthcare facilities, including primary health centers, district hospitals, and medical colleges.
Why This Matters
Human papillomavirus (HPV) is recognized as the principal etiological agent for cervical cancer, which represents a substantial proportion of cancer incidences and fatalities among women in India. The vaccine demonstrates maximal effectiveness when administered prior to the initiation of sexual activity in females, which emphasizes the campaign’s concentration on adolescents at the age of 14 years.
Public health officials assert that by incorporating the HPV vaccine into the standard immunization schedule and launching this expansive campaign, India aspires to significantly diminish the prospective burden of cervical cancer and enhance health outcomes for women across the nation.
MBH/AB